164 related articles for article (PubMed ID: 25854343)
1. Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells.
Du Y; Chen X; Lin XQ; Wu W; Huang ZM
Asian Pac J Cancer Prev; 2015; 16(7):2665-9. PubMed ID: 25854343
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
Chen X; Du Y; Huang Z
Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4.
Chen X; Du Y; Hu Q; Huang Z
Pathol Res Pract; 2017 Mar; 213(3):245-249. PubMed ID: 28214198
[TBL] [Abstract][Full Text] [Related]
4. Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.
Zhou S; Chen L; Qin J; Li R; Tao H; Zhen Z; Chen H; Chen G; Yang Y; Liu B; She Z; Zhong C; Liang C
PLoS One; 2013; 8(9):e73952. PubMed ID: 24023916
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.
Kulhankova K; Rouse T; Nasr ME; Field EH
PLoS One; 2012; 7(9):e43609. PubMed ID: 22984435
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S; Inaba K; Tarbell KV; Steinman RM
Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
[TBL] [Abstract][Full Text] [Related]
7. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
8. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function.
Brinster C; Shevach EM
J Immunol; 2005 Dec; 175(11):7332-40. PubMed ID: 16301639
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressive effects of CD4
Zhou P; Xu J; Dai M; Shi Y; Wu G; Fang Y; Yan X
J Viral Hepat; 2018 Jun; 25(6):733-741. PubMed ID: 29345851
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
13. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
[TBL] [Abstract][Full Text] [Related]
14. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.
Tran GT; Hodgkinson SJ; Carter NM; Verma ND; Plain KM; Boyd R; Robinson CM; Nomura M; Killingsworth M; Hall BM
Blood; 2012 May; 119(19):4441-50. PubMed ID: 22310911
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells.
Fu BM; He XS; Yu S; Hu AB; Ma Y; Wu LW; Tam NL; Huang JF
Exp Clin Transplant; 2009 Sep; 7(3):149-56. PubMed ID: 19715524
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
[TBL] [Abstract][Full Text] [Related]
17. Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo.
Radhakrishnan S; Cabrera R; Schenk EL; Nava-Parada P; Bell MP; Van Keulen VP; Marler RJ; Felts SJ; Pease LR
J Immunol; 2008 Sep; 181(5):3137-47. PubMed ID: 18713984
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
[TBL] [Abstract][Full Text] [Related]
19. CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
Ovcinnikovs V; Ross EM; Petersone L; Edner NM; Heuts F; Ntavli E; Kogimtzis A; Kennedy A; Wang CJ; Bennett CL; Sansom DM; Walker LSK
Sci Immunol; 2019 May; 4(35):. PubMed ID: 31152091
[TBL] [Abstract][Full Text] [Related]
20. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells.
Dumitriu IE; Dunbar DR; Howie SE; Sethi T; Gregory CD
J Immunol; 2009 Mar; 182(5):2795-807. PubMed ID: 19234174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
